Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.

Study metadata

Study type: Original study
Study category (metadata hint): Human
Published: 2024-06-20
Authors: Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM
Journal or registry: AIDS (London, England)
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: NIA NIH HHS; NIDDK NIH HHS; NIAID NIH HHS; NHLBI NIH HHS; NICHD NIH HHS
Identifiers: DOI: 10.1097/qad.0000000000003965 · PMID: 38905488 · PMCID: PMC11365754
First found: Sep 24, 2026
Last found: Sep 25, 2026

Original sources

View at PubMed ↗View at Europe PMC ↗